NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

NEXT STORY
Global ICU Beds Market accounted USD 3.7 Billion in 2019 and is expected to grow with a CAGR of 4.3% during the forecast period – PMI
PREV STORY
Novavax Announces Updates to Leadership Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta

author_avatar
NASDAQ Market News

Aeterna Zentaris Announces Publication of GHD Management Guidelines

author_avatar
NASDAQ Market News

Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California for Stroke IP; Second Pre-Clinical Collaboration Initiated to Test the Efficacy of AST-OPC1 for the Treatment of Stroke

AST-OPC1 has Demonstrated Positive Safety Profile and Promising Signs of Efficacy in a Phase ...

author_avatar
NASDAQ Market News